Conditions: Diabetes Mellitus, Type 2
Keywords: Diabetes Mellitus, type 2 vildagliptin
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 40
Healthy volunteers: no

Brief summary:
This study will assess the efficacy of vildagliptin plus metformin (SPC) treatment in type 2 diabetes mellitus patients uncontrolled by metformin monotherapy after 24 weeks treatment

Detailed description:

Arms:
arm 1: Eligible participants received oral vildagliptin 50 mg plus metformin 500 mg (SPC) twice daily from week 1 to week 24.

Interventions: intervention 1: Vildagliptin
Intervention descriptions: intervention 1: Vildagliptin 50 mg plus metformin 500 mg as Single Pill combination (SPC)

Protocol document: